Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$9.56 ▼ -5.25
(-35.45%)
MKT CAP: $4.33B • VOL: 59.23M
52W L $2 52W H $15
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
IOVA // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>)
SPOT: $9.56
Iovance Biotherapeutics Inc. (IOVA) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).